Loading stock data…
Senseonics Holdings, Inc. (SENS)
$9.33-0.30 (-3.12%)
Market ClosedLast close Sep 8
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Senseonics Holdings, Inc. in the Healthcare sector is trading at $9.33 with a market capitalization of $509M. Wall Street consensus targets $13.40 (5 analysts), implying a +43.6% move over the next 12 months. The stock is currently 19% below its 52-week high of $11.58, remaining 39.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +43.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $14.48M↑ | $11.71M↓ | $14.26M↑ | $8.10M↑ | $6.65M |
| Gross Profit | $8.56M↑ | $6.94M↓ | $7.67M↑ | $3.47M↑ | $3.12M |
| Operating Income | -$35.99M↓ | -$31.85M↓ | -$20.93M↓ | -$19.60M↓ | -$14.32M |
| Net Income | -$36.70M↓ | -$32.33M↓ | -$20.82M↓ | -$19.53M↓ | -$14.50M |
Peer Comparison
JNJUNHPFE
Fundamentals
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$509.18M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.08
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-121.12%
Volume
Today's trading volume
530,328
Recent News
Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue and gross-margin outlook after reporting second-quarter revenue growth of approximately 120% and its highest organic gross margin to date. Net revenue for the second quarter totaled $14.5 million, compared with $
Senseonics Holdings Inc (SENS) (Q2 2026) Earnings Call Highlights: Revenue Soars 120% as ...
Strong US growth and record gross margins drive raised guidance, though increased investment costs widen net loss.
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of -14.55% and +10.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates
KORU Medical Systems, Inc. (KRMD) delivered earnings and revenue surprises of +150.00% and +2.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Omnicell (OMCL) Q2 Earnings and Revenues Top Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of +95.83% and +0.83%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?